WebThilo Hackert 1 , Jens Werner, Jürgen Weitz, Jan Schmidt, Markus W Büchler. Affiliation 1 Department of Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany. PMID: 20582600 DOI: 10.1007/s00423-010-0663-9 Abstract Purpose ... WebThere were 183 total pancreatectomies, 113 partial pancreatoduodenectomies, 79 distal pancreatectomies, and 10 resections for tumor recurrences, including 121 multivisceral resections and 171 venous resections. Forty-three patients (11.4%) had resectable oligometastatic disease. All of the 190 patients undergoing PAD (100%) and 95 of the …
Home [www.hackatl.org]
WebThilo Hackert 1 , Milena Sachsenmaier, Ulf Hinz, Lutz Schneider, Christoph W Michalski, Christoph Springfeld, Oliver Strobel, Dirk Jäger, Alexis Ulrich, Markus W Büchler Affiliation 1 *Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany †Department of Medical Oncology, University ... WebAiste Gulla 1 , Povilas Ignatavicius 2 , Camilo Correa 3 , Yosuke Inohue 4 , Daisuke Hashimoto 5 , Daisuke Ban 6 , Ulrike Heger 7 , Doris Wagner 8 , Qinfen Xie 9 , Perry Shen 10 , Arthur L Michel 11 , Jan Lerut 12 , Marco Del Chiaro 13 , Thilo Hackert 7 , Christopher L Wolfgang 3 , Jin He 14 , Peter Kingham 15 , Timothy M Pawlik 16 , Sohei ... fcba lynette
Stimulation of Central α2 Receptors Attenuates Experimental ... - LWW
WebDec 20, 2024 · Thilo Hackert MD, PhD 15, Asif Halimi MD 16, Tobias Keck MD, PhD 17, Jörg Kleeff MD, PhD 18, Ulla Klaiber MD 15, Knut J. Labori MD, PhD 19, Mickael Lesurtel MD, PhD 20, Giuseppe Malleo MD, PhD 7, Marco V. Marino MD 21,22, I. Quintus Molenaar MD, PhD 23, Michael B. Mortensen MD, PhD 24, Andrej Nikov MD 25, Michele … WebObjective: For patients with locally advanced and unresectable pancreatic cancer (PDAC), neodadjuvant treatment and consecutive surgical exploration have been studied during the last decade with various neoadjuvant therapies including chemotherapy and combinations with radiation. Aim of the study was the evaluation of neoadjuvant therapy with a ... WebConversion rate was 10.9% for MIDP and 8.4% for MIPD. Overall 90 day mortality was 1.1% (n = 6) for MIDP and 3.7% (n = 15) for MIPD. Conclusion: Within the E-MIPS registry, MIDP is performed in about half of all patients, mostly using laparoscopy. MIPD is performed in about a quarter of patients, slightly more often using the robotic approach. fc balzers